Janus Henderson Investors

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

Ovid Therapeutic's purpose is to solve intractable medical problems.

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Relmada Therapeutics is a biotech company addressing diseases of the central nervous system, with a focus on major depressive disorder.

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

CesiumAstro provides out-of-the-box communication systems for satellites, UAVs, launch vehicles, and other space or airborne platforms.